The global Artificial Intelligence (AI) in Medical Diagnostics Market size is expected to reach USD 12.2 billion and is projected to reach a CAGR of 33.9% from 2023-2030.
The use of AI technologies and algorithms in the area of medical diagnostics is referred to as artificial intelligence (AI) in the medical diagnostics market. By facilitating more precise and effective medical image processing, data interpretation, and decision-making, AI has the potential to revolutionize medical diagnostics.
In recent years, the market for AI in medical diagnostics has grown significantly. Large medical datasets are becoming more widely available, medical imaging methods are being used more often, and AI algorithms are all contributing to this rise. AI may help medical personnel identify, diagnose, and keep track of a wide range of illnesses and problems, such as cancer, cardiovascular issues, neurological disorders, and more.
The market for artificial intelligence in medical diagnostics includes a number of imaging modalities, including radiology (X-rays, CT scans, MRI), pathology (digital pathology and histology), and other diagnostic methods. AI algorithms are able to analyze medical pictures and offer insights, aid in the early diagnosis of diseases, and aid in the creation of individualized treatment regimens. AI may also help with risk appraisal, prognosis prediction, and therapy response analysis.
The market is also fueled by factors such as the rising burden of chronic illnesses, the desire to improve healthcare outcomes while lowering costs, and the rising need for precise and efficient diagnostic solutions. Additionally, regulatory agencies and healthcare organizations are taking action to develop rules and frameworks to ensure AI's safe and successful incorporation into clinical practice as they see the promise of the technology in diagnostics.
The COVID-19 pandemic, which is still going on, revealed the flaws in the current healthcare system and sped up the use of digital technology, including AI in diagnostics, to precisely analyze complicated information and lessen the administrative and operational strain on physicians. The expansion of the market was helped by the creation of startups and increased recognition in the form of funding & investments. Healthcare firms adopted AI-powered technologies quickly, and they were rewarded with money from venture capitalists and favorable government backing. For instance, Arterys secured USD 28 million in Series C funding in May 2020 under the leadership of Benslie Investment Group and Temasek Holdings in order to broaden its product line.
The AI in the Medical Diagnostics market is a vibrant and quickly developing sector of the economy. The market may be described as being both fragmented and consolidated. While there are many different participants, including startups, research institutes, and specialized AI solution providers, existing healthcare organizations and large technology firms also play a vital role. The rising availability of medical data, improvements in machine learning and deep learning techniques, and the expanding need for quicker and more accurate diagnosis are some of the reasons driving the market. The market dynamics might fluctuate across various applications, technologies, and geographical areas, despite the fact that several sectors, such as radiology and pathology, have demonstrated tremendous development and promise. It's vital to remember that the market for artificial intelligence in medical diagnostics is expected to keep altering due to continuous technological breakthroughs, regulatory concerns, and shifting healthcare requirements. For both established and up-and-coming competitors in this sector, keeping an eye on the most recent innovations, alliances, and market trends will be essential.
North America to Dominate the Market
|
Report Feature |
Descriptions |
|---|---|
|
Growth Rate |
CAGR of 33.9% during the forecasting period, 2023-2030 |
|
Historical Data |
2019-2021 |
|
Forecast Years |
2023-2030 |
|
Base Year |
2022 |
|
Units Considered |
Revenue in USD million and CAGR from 2023 to 2030 |
|
Report Segmentation |
Application, technology, and region. |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East, and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, and South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
IBM Corporation, Google LLC (Alphabet Inc.), Microsoft Corporation, NVIDIA Corporation, General Electric Company (GE Healthcare), Siemens Healthineers AG, Aidoc Medical Ltd., Butterfly Network Inc., Zebra Medical Vision Ltd., AliveCor Inc., Intel Corporation, Digital Diagnostics, Inc., Xilinx (US), InformAI LLC, HeartFlow, Inc., Enlitic, Inc., Day Zero Diagnostics, Inc, Aidence, Prognos Health, Nanox AI, Viz.ai, Inc., Quibin, Qure.ai, Therapixel, Koninklijke Philips N.V., Lunit. Inc., EchoNous Inc. |
|
Available Customization |
In addition to the market data for Artificial Intelligence (AI) in Medical Diagnostics Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements. |
Artificial Intelligence (AI) in Medical Diagnostics Market is segmented into various segments such as application, technology, and region:
On the basis of application
On the basis of technology
On the basis of region
The prominent players in Artificial Intelligence (AI) in Medical Diagnostics Market are
.png)
.png)
.png)
.png)
.png)
.png)